Quantitative determination of MDRI mRNA expression in peripheral blood lymphocytes: A possible role of genetic polymorphisms in the MDRI-gene

European Journal of Clinical Investigation

Volumn 33, Issue 3, 2003, Pages 261-267

  Oselin, Kersti ^a,b,c   Nowakowski Gashaw, I ^a,c   Mrozikiewicz, P M ^a,c   Wolbergs, D ^a,c   Pahkla R ^b   Roots, I ^a,c  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF TARTU   (Estonia)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

MDR1 genetic polymorphism; MDR1 mRNA expression; P glycoprotein; Peripheral blood lymphocytes

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG; DNA; LEUKOCYTE ANTIGEN;

ADULT; AMINO TERMINAL SEQUENCE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; FLOW CYTOMETRY; GENE; GENE AMPLIFICATION; GENE EXPRESSION; GENOTYPE; ISOLATION AND PURIFICATION; LYMPHOCYTE; METABOLISM; METHODOLOGY;

ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD56; ANTIGENS, CD8; DNA; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE EXPRESSION; GENES, MDR; GENOTYPE; HUMANS; LYMPHOCYTES; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0037353758     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2003.01133.x     Document Type: Article

References (22)

1. Sonneveld P. Multidrug resistance in haematological malignancies. J Intern Med 2000;247:521-34.
2. Plaat BEC, Hollema H, Molenaar WM, Broers GHT, Pijpe J, Mastik, MF et al. Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol 2000;18:3211-20.
3. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 1992;80:2729-34.
4. Ludescher C, Pall G, Irschick EU, Gastl G. Differential activity of P-glycoprotein in normal blood lymphocyte subsets. Br J Haematol 19983101:722-7.
5. Gupta S, Kim CH, Tsuruo T, Gollapudi S. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+ T cells: a role in cytotoxic effector function. J Clin Immunol 1992;12:451-8.
6. Klimecki WT, Taylor CW, Dalton WS. Inhibition of cell-mediated cytolysis and P-glycoprotein function in natural killer cells by verapamil isomers and cyclosporine A analogs. J Clin Immunol 1995;15:152-8.
7. Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M et al. Involvement of P-glycoprotein in the transmembrane transport of intefieukin-2 (IL-2), IL-4, and interferon-γ in normal human T lymphocytes. Blood 1996;88:1747-54.
8. Raghu G, Park SW, Roninson IB, Mechetner EB. Monoclonal antibodies against P-glycoprotein, an MDR1 gene product, inhibit interleukin-2 release from PHA-activated lymphocytes. Exp Hematol 1996;24:1258-64.
9. Hoffmeyer S, Burk O, von Richter O, Arnold HP, Brockmöller J, Johne A et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473-8.
10. Fellay J, Marzolini C, Meaden ER, Back DJ, Buclin T, Chave J-P et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002;359: 30-6.
11. von Ahsen N, Richter M, Grupp C, Ringe B, Oellerich M, Armstrong VW et al. No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients. Clin Chem 2001;47:1048-52.
12. Trambas C, Wang Z, Cianfriglia M, Woods G. Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein. Br J Haematol 2001;114: 177-84.
13. Nauck M, Stein U, von Karger S, März W, Wieland H. Rapid detection of the C3435T polymorphism of multidrug resistance gene 1 using fluorogenic hybridization probes. Clin Chem 2000;46:1995-7.
14. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000;25:169-93.
15. Asghar A, Gorski JC, Haehner-Daniels B, Hall SD. Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. Drug Metab Dispos 2002;30:20-6.
16. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999;39:361-98.
17. Ma JF, Grant G, Staelens B, Howard DL, Melera PW. In vitro translation of 2.3-kb splicing variant of the hamster pgp1 gene whose presence in transfectants is associated with decreased drug resistance. Cancer Chemother Pharmacol 1999;43:9-28.
18. Kawai K, Kusano I, Ido M, Sakurai M, Shiraishi T, Yatani R. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells. Biochem Biophys Res Commun 1994;198:804-10.
19. + natural killer cells. Pharmacogenetics 2001;11:293-8.
20. + hematopoietic stem cells. Haematologica 2002;87:564-8.
21. Nakamura T, Sakaeda T, Horinouchi M, Tamura T, Aoyama N, Shirakawa T et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 2002;71:297-303.
22. Gribar JJ, Ramachandra M, Hrycyna CA, Dey S, Ambudkar SV. Functional characterization of glycosylation-deficient human P-glycoprotein using a vaccinia virus expression system. J Membr Biol 2000;173:203-14.